Aytu BioScience' GAAP loss for 9 months of fiscal year 2021 was $39.291 million, up 3.8 times from $10.476 million in the previous year. Revenue increased 3.3 times to $42.15 million from $12.771 million a year earlier.
Aytu BioScience' GAAP loss for 9 months of fiscal year 2021 was $39.291 million, up 3.8 times from $10.476 million in the previous year. Revenue increased 3.3 times to $42.15 million from $12.771 million a year earlier. 
irdirect.net
English (US) 